[
    [
        {
            "time": "2019-01-24",
            "original_text": "石药集团：综合创新药龙头的成功秘诀",
            "features": {
                "keywords": [
                    "石药集团",
                    "创新药",
                    "龙头"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "石药集团：综合创新药龙头的成功秘诀",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-01-24",
            "original_text": "辰欣药业：58万元贱卖两款新药 不搞研发热心理财",
            "features": {
                "keywords": [
                    "辰欣药业",
                    "新药",
                    "研发",
                    "理财"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "辰欣药业：58万元贱卖两款新药 不搞研发热心理财",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-01-24",
            "original_text": "24家证券机构认为“4+7带量采购”落地，给行业带来的影响是这样的",
            "features": {
                "keywords": [
                    "4+7带量采购",
                    "证券机构",
                    "行业影响"
                ],
                "sentiment_score": 0.3,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "24家证券机构认为“4+7带量采购”落地，给行业带来的影响是这样的",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 6,
                "Market_Scope": 10,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-01-24",
            "original_text": "恒瑞医药：盐酸右美托咪定氯化钠输液获FDA暂时批准",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "FDA",
                    "药品批准"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "恒瑞医药：盐酸右美托咪定氯化钠输液获FDA暂时批准",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-01-24",
            "original_text": "医疗保健：预期趋稳 估值逐步修复",
            "features": {
                "keywords": [
                    "医疗保健",
                    "预期趋稳",
                    "估值修复"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗保健"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医疗保健：预期趋稳 估值逐步修复",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-01-24",
            "original_text": "兴证王德伦：股票仓位大幅下降 消费板块超配比例较高",
            "features": {
                "keywords": [
                    "股票仓位",
                    "消费板块",
                    "超配"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "消费"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "兴证王德伦：股票仓位大幅下降 消费板块超配比例较高",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-01-24",
            "original_text": "医疗保健：继续强烈推荐创新服务商+注射剂国际化 荐30股",
            "features": {
                "keywords": [
                    "医疗保健",
                    "创新服务商",
                    "注射剂国际化"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗保健"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "医疗保健：继续强烈推荐创新服务商+注射剂国际化 荐30股",
                "Correlation": 7,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-01-24",
            "original_text": "药品集中采购和使用试点方案出台 医药股受机构推荐",
            "features": {
                "keywords": [
                    "药品集中采购",
                    "试点方案",
                    "医药股"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "药品集中采购和使用试点方案出台 医药股受机构推荐",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 10,
                "Impact": 9,
                "Duration": 10,
                "Entity_Density": 7,
                "Market_Scope": 10,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-01",
            "original_text": "2019年1月医药生物行业投资策略:预期趋稳,估值逐步修复",
            "features": {
                "keywords": [
                    "医药生物",
                    "投资策略",
                    "预期趋稳",
                    "估值修复"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "2019年1月医药生物行业投资策略:预期趋稳,估值逐步修复",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        }
    ]
]